Alongside ULK1 activators, Martin and colleagues identified two ULK1 small-molecule inhibitors, ULK-100 and ULK-101, which can disrupt autophagy, making tumor cells more sensitive to nutrient depletion [113]. Here, ULK1 is linked to neoplasm.